Business Wire

WIKIFARMER

Share
Wikifarmer Democratizes Agricultural Commerce. Put Simply, It Enables Farmers to Sell Directly to Businesses at Higher Margins and Educates Them on Modern Farming Techniques

Wikifarmer, the direct farmer-to-business agricultural marketplace—aptly described as the “Wikipedia of farming”—has raised a €5M in a late seed round, led by Point Nine.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005806/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Ilias Sousis and Petros Sagkos, founders of Wikifarmer (Photo: Business Wire)

The Athens-based startup will use the funding for pan-European expansion and to enrich its knowledge library. It will further enhance its platform to fully digitize transactions end-to-end, and offer innovative financial and logistic solutions to both buyers and sellers.

As a whole, Wikifarmer is an ecosystem that supports farmers from start to finish. It enables them to learn, sell and make their business lives easier.

On the supply side, farmers receive the value they deserve: they produce more efficiently, sell directly, and enjoy an increase in their profitability by up to 300%. Higher profitability for farmers means a higher capacity for investments in production, higher employment, and higher sustainability.

On the demand side, Wikifarmer acts as a purchasing assistant for B2B buyers, such as wholesalers, larger hotels, restaurant chains, small and medium size retailers, or food processing units. It provides hassle-free sourcing of agricultural products, helps parties to negotiate prices efficiently online, offers logistics support, ensures security and transaction transparency and facilitates 60 - 90 days of credit.

What’s next?

“Our vision is to restructure the supply chain, digitize processes, and ultimately generate more value for all parties involved. Our mission is to become Europe’s leading B2B trading platform within the next two years. This round of funding will allow us to accelerate our product development in order to offer 360° coverage of agricultural transactions” explains Wikifarmer’s Co-Founder and CEO, Ilias Sousis.

Petros Sagos, Co-Founder and Chief Science Officer, concludes: “Above all, we hope this funding will enable us to turn our long-standing vision into reality: democratize agriculture and support farmers in modernizing their techniques, selling their products, and earning the value they deserve"

Point 9 is a B2B SaaS and B2B marketplace-specialized VC firm with investments such as Revolut, Delivery Hero, Docplanner, and cargo.one and one of the highest “seed-to-winner” rates in the industry. The round was complemented by relevant Business Angels (the founders of cargo.one, Nikos Moraitakis - co-founder and CEO of Workable, Przemyslaw Budkowski - CEO of Merxu, Cihan Aksakal - founder of Zenjob, Louis Pfizner - founder of Caya.com and Treatwell), as well as prior investors including leading Greek VC Metavallon, plus angels such as Sophia Bendz.

“B2B marketplaces, which bring mostly analog industries online, are a core area of focus for us at Point Nine. We have been partnering with one or two new B2B marketplaces every year, for the last 7 years, including REKKI (restaurants) in 2016, Container xChange (containers) and Laserhub (metal parts) in 2017, cargo.one (air cargo) in 2018, MerXu (industrial products) in 2019, Rooser (seafood) in 2020, and now Wikifarmer. The food industry is gigantic and presents its own challenges, but we’ve been impressed by Ilias’s and Peter’s unique approach to digitizing the industry. We’re excited to play a small role in their long-term success” says Louis Coppey, partner at Point Nine.

The Industry and Context

In addition to being the no.1 employer[1] in the world, the agrifood industry generates a total turnover of 1.2 trillion Euros in Europe alone[2] and has a major impact on the everyday life of every single person on the planet. Yet, a significant number of farmers still lack access to modern agricultural best practices, and it remains one of the least digitized sectors. The pandemic, the outbreak of the war in Ukraine, along with climate change, population growth predictions, and the scarcity of natural resources have all had a major impact on the supply chain, and eventually, the food on our plates. The past few years have been challenging for the agrifood sector, placing increased demands on food security and sustainable solutions. Wikifarmer responds to the need for new technologies and ideas that have the potential to reshape agriculture, and this is reflected in the startup’s growth.

The Product

Wikifarmer is an ecosystem of content and agricultural products that promote a fairer, more transparent and sustainable value chain in the food industry. With Wikifarmer, farmers can sell their output to multiple buyers, achieve a better price, monitor fair market prices, and access international markets. The startup also offers instant payments to farmers and helps them with logistics and financing, allowing them to increase their profitability on the Wikifarmer marketplace. At the same time, it provides them with a wide collection of agricultural best practices and how-to guides, which have been translated into 16 languages and are freely accessible on the Wikifarmer Library.

On the platform, farmers can use the Wikifarmer library to upgrade their techniques, in order to improve the quality of their produce and boost their efficiency. Then, they can upload their products on the Wikifarmer Market and sell directly to buyers from all over the world.

The story behind the startup

Looking back to where everything started, the founding team is a metaphor for Wikifarmer's mission: matching digitization with agricultural science. CEO Ilias Sousis, a senior ex-Googler for 11 years, and Chief Science Officer Petros Sagos, an accomplished agronomist, have been best friends since primary school. "We started Wikifarmer because we thought things should be done differently" they explain.

Today, Wikifarmer is approaching 1m unique visitors per month. It has allowed thousands of businesses to slash costs by up to 30%, enabling farmers to sell their products without intermediaries, while growing their potential clientele, reducing waste, and tripling their profitability. The Wikifarmer library has been dubbed the “Wikipedia of Farming” by the United Nations and is now available in 16 languages.

About Wikifarmer

Wikifarmer is a global platform whose mission is to empower farmers by offering them education as well as direct access to commercial markets, so they can sell their products at fair prices.

About Point Nine

Founded in 2011, Point Nine is a European early-stage venture capital firm focused on B2B SaaS and B2B marketplace start-ups in Europe and North America. The firm is a seed investor in more than 150 companies in over 30 countries, including Algolia, Brainly, Chainalysis, Clio, Contentful, Delivery Hero, DocPlanner, Front, Loom, Mambu, Revolut, and Typeform, amongst others. Point Nine has one of the highest “seed-to-winner” rates in the industry.

About Metavallon

Metavallon VC specializes in pre-seed and seed-stage funding of disruptive technology companies. The firm invests in and works alongside ambitious entrepreneurs, helping them build transformational businesses across multiple stages, geographies and industries. Metavallon VC’s mission is to engage at a very early stage and invest in companies that will operate at the forefront of business and technology innovation.

[1] United Nations, 2017
[2] https://www.opendei.eu/agri-food-sector/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005806/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye